Clinical Trial Update: SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction [Phase 4]

View source ↗

Summary

Phase 4 trial of SHengXiaN-QuYu Decoction for heart failure with reduced and mildly reduced ejection fraction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• SHengXiaN-QuYu Decoction

Snippet

Sponsor: China-Japan Friendship Hospital | Conditions: Heart Failure | Phase 4 | Status: RECRUITING